Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yaoji Industrial Investment is the strategic investment arm of Shanghai Yaoji Technology Co., Ltd., a prominent Chinese corporation formerly known for its playing card manufacturing. The firm was established to spearhead the parent company's expansion into the life sciences, specifically targeting high-growth areas such as biotechnology and healthcare services. Its most significant venture was a major investment in Cellular Biomedicine Group (CBMG), which focuses on developing advanced CAR-T cell therapies and stem cell treatments for cancer and degenerative diseases. By operating as a corporate venture capital entity, Yaoji Industrial Investment provides capital and strategic support to innovative medical technology firms. The company's activities reflect a broader trend of traditional Chinese industrial firms diversifying into the global healthcare innovation ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yaoji Industrial Investment.